EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS130-16327 
Organism
Homo sapiens 
Tissue/cell
MDA-MB-231 
Coordinate
chr21:34754790-34757000 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
Foxd3MA0041.1chr21:34756589-34756601GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr21:34756593-34756605GTTTGTTTGTTT+6.32
Klf1MA0493.1chr21:34756066-34756077AGCCACACCCT+6.02
USF1MA0093.2chr21:34755676-34755687GCCACGTGACC+6.62
USF2MA0526.2chr21:34755674-34755690GCGCCACGTGACCCAG-6.69
Number of super-enhancer constituents: 12             
IDCoordinateTissue/cell
SE_00219chr21:34750982-34756583Adipose_Nuclei
SE_09780chr21:34750609-34758167CD14
SE_10653chr21:34751101-34757835CD19_Primary
SE_10924chr21:34750502-34759616CD20
SE_27036chr21:34754548-34756615Esophagus
SE_36753chr21:34754454-34756616HMEC
SE_53413chr21:34751185-34757173Spleen
SE_58466chr21:34731200-34786233Ly1
SE_60169chr21:34732700-34761220Ly4
SE_60632chr21:34732666-34757447DHL6
SE_61512chr21:34731229-34778660Toledo
SE_64665chr21:34754499-34756570NHEK
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr213475529634756154
Number: 1             
IDChromosomeStartEnd
GH21I033378chr213475110834757769
Enhancer Sequence
ACAAATGCTA CTAAGCCCAG GCCCTTATCC AGCCAAAACC ATCCTGCCAA GCTCCCACCA 60
CCACCATCAG CATCATTTTC AGGTTGTTGG TCATCACTGG TTGTTGGTCA TCACTGGTTG 120
TTGGTCATCT ATGTCACCTA ACAGGCCACT CATGACGTTA GCCCTTGACT TCAAAAAGGA 180
CCTCAAAGAA AATTCCAGTT TTCACTCCAA AAGGAGAAAT CAGGCCGAGC TGTGATGGCT 240
CATGCCTGTA TTCCCAGCAC TATGGGAGGC TGAGGCAGGC GGATCGCTTG AGCCCAGGAG 300
TTTGAGACCA CCCTGGGCAA ACCTATCTTT CCAAAAAAAT ACAAAAAGAT TAGCTGGGCA 360
TGGTGGTGCG TGCCTGTAGT CTCAGCTAGT CAGGAGGCTG AGGTGGGAGG ATCACTTAAG 420
CCTGGAAGGT TGAGGCTGCA GTGAGCGGTG ATGGTGCCAC TGCACTCCAG CCTGGATAAC 480
AGAGCAAGAT GCTGTCTCAA AAACTAGCAA ACGAAACAAA AGGAGAAACT GCTGGCAGCC 540
CCTAATCTAG TACTGTCCCG GCTCCACCCA CCTTCAGATC CAGCCTCCTC CCCTGGCACA 600
CGGGAGCCCC CTCCTCTGAC TGTGCTGAAA GTGAGGGAAG ATCCCCTCTG GGGAGAGAGC 660
TGTAGCCTTG ACCTCTGCAC ACCTTACTTA TCCAGAGCAC GAGGCAGGGC CGCTGACTCA 720
TCCTGGTTTA CCCTGGGCTT TCCCAGTTTC AGCACTGAAA GTCCCGCATC TGGAAAAGCC 780
CCTGAGTCGC TGACAAACCA GACAGTCCGG ACCATGCAAA GCACAGTGCA TGGTGCTTTA 840
GCCACAAAGT TGATTGAAAA GTCAGAGGCA GTGAGCCACA GGAAGCGCCA CGTGACCCAG 900
ACTGCGAGGA GGACACAGGA AACCAACCCT CACTGTGTCC TGCTAGGGGG TTAACCCGTC 960
TACAAGCATC AGGGTTGCCA TTTCAGAGAT CAGCAAACTG AACAGCAGTC GTGACTTGTC 1020
CTCGCCTGCA AGACAAGCGA GTAACAAATC CATGAAGGGA AGGACACGGA ATTGAGCAAG 1080
GGGGCAGGGC CGGATGTCAT TTTGGCGTTT TTTTTTCTTT CAGTGATTGA GGTAAAATTC 1140
ACATAACATA AATTAACCAT TTTAAAGTGT ACGATTCAGA GGCATTTGGT ACATTCACAC 1200
TGTTGTGCAA GCACCACCTG TATCTCGTTC CAAAATATTT TCACTTCCCC AAAAGGAAAC 1260
TGTGTCCCCA TCAAGCAGCC ACACCCTACT CCCTCACCCC CGCCCCCAGC CTCTGACAAC 1320
CACCAATGTA CCTTTTGTCT CTATGGATTT GCCTTTACTG AACAATTCAT AGTAATGGAA 1380
CCATACAATA TGTAGTCCTT TGCGACTGGC TTTTTTTACT CAGCATCAAT TTTTTTTTCT 1440
TTTTCTTCGA GACAGAGTCT TGCTCTGTCA CCCCGGCTGG AGTGCAGTGG CATGATCTCG 1500
GCTCACTGCA ACCTCCACCT CCTGGGCTCA AGCGATTCAC ATGCTTCAGC CTTCTGAGTA 1560
GCTGGGACTG CAGGTGTGCA CCACCATGCA TGGCTAAATT TTTTTTTTTT TTTTTTTTTT 1620
TTTTTTTTTT TTTTTTTTAG AGAGGGAGGT CTTACTACAT TGCCCAGACT GGTCTCAAAC 1680
TCCTGGCCTC AAGCAATCCT CCTTCCTCGG CTTCTCAAAG TGCTGGGATT ACAGGCTTGA 1740
GCCATCACGC CCAGCCTATC ATCCTAGTTT TGTTTTTTGG GTTTTTTGTT TGTTGGTTGG 1800
TTTGTTTGTT TGTTTTTGAG ACCTAGTTTC ACTCTTGTCA CCCAGGCTGG AGTGCAATGG 1860
TGCAATCTTG GCTCACTGCA ACCTCCGCCT CCTGGGTTCA AGTGATTCTC CTGCCTCAGC 1920
CTCTCAAGTA GTTGTGACTA CAAGCATGCG CCACCACACC TGGCTAATTT TTGTATTTTT 1980
AGTAGAGACA GGGTTTCACC ATATTGTCCA GCCTGATCTC AAACCCCTGA TCTCAAGTGA 2040
TCCTCCCACT TTGGCCTCCC AAAGTGCTGG GATTTCAAGT GTGAGCCACC GTGCCCGGCT 2100
GCCTCATCAA TTCTCTATAA ACAGTTATTA ATGAGAAGTC AGTTGAGCTG TTTCTATGTA 2160
TTTGTTTCCA GAAAGAAACA GGGTGCACCT AGACCACCCT GGACCTCAGT 2210